• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第三代头孢菌素在人体腹膜组织中的穿透情况。

Penetration of third-generation cephalosporins into human peritoneal tissue.

作者信息

Berger S A, Dan M, Serour F, Gorea A, Levenberg A, Krispin M

机构信息

Department of Microbiology, Tel-Aviv Medical Center, Israel.

出版信息

Chemotherapy. 1989;35(5):326-9. doi: 10.1159/000238689.

DOI:10.1159/000238689
PMID:2676403
Abstract

Each of 40 patients underwent elective laparotomy following administration of a single 1.0-gram intravenous dose of ceftizoxime, ceftriaxone, cefoperazone or cefotaxime. Therapeutic concentrations of cefoperazone and ceftriaxone were achieved in peritoneal tissue in 20/20 patients. Only 9/20 samples from patients receiving the other two antibiotics had detectable antibiotic activity. The antibiotic concentration in peritoneal fluid (7 samples) was 2.36-11.15 times higher than that of concurrently obtained peritoneal tissue. When adjusted for the in vitro susceptibility (MIC) of potential peritoneal pathogens, our data suggest that ceftriaxone and cefoperazone may be preferable to other third-generation cephalosporins for the prophylaxis and therapy of intraabdominal infection.

摘要

40名患者在静脉注射单次1.0克剂量的头孢唑肟、头孢曲松、头孢哌酮或头孢噻肟后均接受了择期剖腹手术。20/20例患者的腹膜组织中达到了头孢哌酮和头孢曲松的治疗浓度。接受其他两种抗生素治疗的患者中,只有9/20的样本具有可检测到的抗生素活性。腹膜液(7个样本)中的抗生素浓度比同时获取的腹膜组织中的抗生素浓度高2.36 - 11.15倍。根据潜在腹膜病原体的体外药敏试验(MIC)进行调整后,我们的数据表明,对于腹腔内感染的预防和治疗,头孢曲松和头孢哌酮可能比其他第三代头孢菌素更具优势。

相似文献

1
Penetration of third-generation cephalosporins into human peritoneal tissue.第三代头孢菌素在人体腹膜组织中的穿透情况。
Chemotherapy. 1989;35(5):326-9. doi: 10.1159/000238689.
2
[Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].[从临床样本中分离出的某些细菌对第三代头孢菌素的敏感性]
Mikrobiyol Bul. 1987 Oct;21(4):279-83.
3
Third generation oral cephalosporins: comparative in vitro kinetics.第三代口服头孢菌素:体外动力学比较
J Chemother. 1995 May;7 Suppl 1:9-12.
4
Potencies of ceftriaxone and cefotaxime in a single chamber pharmacokinetic system simulating their in vivo half-lives.在模拟头孢曲松和头孢噻肟体内半衰期的单室药代动力学系统中的效价。
Chemotherapy. 1989;35(5):338-44. doi: 10.1159/000238692.
5
[Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].[第四代头孢菌素对肠杆菌科临床分离株的活性]
Rev Med Chir Soc Med Nat Iasi. 2003 Jul-Sep;107(3):595-8.
6
Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
Clin Ther. 1991 Sep-Oct;13(5):596-605.
7
Protein binding of ceftriaxone, cefoperazone, and ceftizoxime.头孢曲松、头孢哌酮和头孢唑肟的蛋白结合率。
Clin Pharm. 1987 Jul;6(7):567-9.
8
Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty.头孢地嗪和头孢曲松在髋关节置换术患者血清和骨骼中的药代动力学研究。
Antimicrob Agents Chemother. 1997 Oct;41(10):2292-4. doi: 10.1128/AAC.41.10.2292.
9
In vitro antibacterial activity of ceftizoxime against gram-negative strains.
Chemioterapia. 1985 Apr;4(2):166-9.
10
[Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].[头孢噻肟与其他头孢菌素相比的抗菌活性的微生物学评价]
Boll Ist Sieroter Milan. 1982;61(4):300-8.

引用本文的文献

1
Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.头孢曲松:其在社区获得性感染和医院感染管理中应用的最新情况
Drugs. 2002;62(7):1041-89. doi: 10.2165/00003495-200262070-00005.
2
Management of infections due to antibiotic-resistant Streptococcus pneumoniae.耐抗生素肺炎链球菌所致感染的管理
Clin Microbiol Rev. 1998 Oct;11(4):628-44. doi: 10.1128/CMR.11.4.628.
3
Concentrations in plasma and tissue penetration of ceftriaxone and ornidazole during liver transplantation.肝移植期间头孢曲松和奥硝唑的血浆浓度及组织穿透性
Antimicrob Agents Chemother. 1993 Sep;37(9):1873-6. doi: 10.1128/AAC.37.9.1873.
4
Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients.比较头孢曲松与头孢尼西治疗肝硬化患者自发性细菌性腹膜炎的随机试验。
Antimicrob Agents Chemother. 1993 Aug;37(8):1587-92. doi: 10.1128/AAC.37.8.1587.
5
Cefotaxime. An update of its pharmacology and therapeutic use.头孢噻肟。其药理学与治疗应用的最新进展。
Drugs. 1990 Oct;40(4):608-51. doi: 10.2165/00003495-199040040-00008.